베타
임상 레이더 AI
임상시험 NCT07494591은(는) Ipsilateral Shoulder Pain, 비디오 보조 흉강경 수술에 대해 대상자모집전 상태입니다. 모든 세부 정보를 보려면 임상시험 레이더 카드 뷰와 AI 발견 도구를 확인하거나 여기에서 무엇이든 물어보세요.
하나의 임상시험이 필터 기준과 일치합니다.
카드 뷰

TEAS for Ipsilateral Shoulder Pain After Video-Assisted Thoracoscopic Lung Surgery 216 비침습

대상자모집전
임상시험 세부 정보는 주로 영어로 제공됩니다. 하지만 임상 레이더 AI가 도와드릴 수 있습니다! '임상시험 설명'를 클릭하여 선택한 언어로 임상시험 정보를 확인하고, 이에 대해 AI와 논의해 보세요.
임상시험 NCT07494591은(는) Ipsilateral Shoulder Pain, 비디오 보조 흉강경 수술에 대해 알아보는 중재연구입니다. 현재 상태는 대상자모집전이며, 2026년 4월 1일부터 참여 신청이 가능합니다. 216명의 참여자를 모집할 예정입니다. Shanghai Pulmonary Hospital, Shanghai, China이(가) 진행하는 이 연구는 2026년 12월 30일까지 진행될 예정입니다. ClinicalTrials.gov의 가장 최근 정보는 2026년 3월 27일에 갱신되었습니다.
간단한 개요
Shoulder pain is a common problem after certain types of lung surgery called video-assisted thoracoscopic surgery (VATS). This study examines whether a treatment called transcutaneous electrical acupoint stimulation (TEAS) can help reduce this pain. TEAS is a non-invasive technique that uses mild electrical stimulation at specific points on the body.Patients who are having VATS lung surgery will be randomly assigned ...더 보기
상세한 설명
Ipsilateral shoulder pain (ISP) is a common and often debilitating complication following video-assisted thoracoscopic surgery (VATS) for lung surgery, significantly impacting patient recovery and quality of life. Current pain management strategies are not always fully effective in preventing or alleviating ISP. Transcutaneous Electrical Acupoint Stimulation (TEAS) is a non-pharmacological intervention that has shown...더 보기
공식 제목

Preoperative Transcutaneous Electrical Acupoint Stimulation for Ipsilateral Shoulder Pain After Video-Assisted Thoracoscopic Lung Surgery: A Multi-Center, Single-Blind, Randomized Controlled Trial

질환명
Ipsilateral Shoulder Pain비디오 보조 흉강경 수술
기타 연구 식별자
  • L25-604
NCT 번호
실제 연구 시작일
2026-04-01
최신 업데이트 게시
2026-03-27
예상 연구 완료일
2026-12-30
계획된 등록 인원
216
연구종류
중재연구
단계/상
해당 없음
상태
대상자모집전
주요 목적
치료
설계 할당
무작위배정
중재 모델
평행설계
맹검 (마스킹)
이중맹검
시험군 / 개입
참가자 그룹/시험군개입/치료
실험적TEAS Group
Participants will receive preoperative transcutaneous electrical acupoint stimulation (TEAS) . TEAS will be administered for 30 minutes twice: (1) the evening before surgery and (2) before anesthesia induction on the day of surgery.
TEAS
TEAS is a non-invasive transcutaneous electrical stimulation procedure. The TEAS device delivers a sparse-dense waveform. The current intensity is set within a range of 2-20 mA. The intervention administrator adjusts the current intensity within the pre-defined safety limits according to patient tolerance to maintain a mild soreness/"deqi" sensation. TEAS will be delivered twice for 30 minutes each: in the evening th...더 보기
거짓 대조군Sham TEAS Group
The control group receives a sham stimulation procedure with sensory matching. Sham TEAS will be administered for 30 minutes twice: (1) the evening before surgery and (2) before anesthesia induction on the day of surgery.
Sham TEAS
he sham procedure is a sensory-matched inactive stimulation. During the first 30 seconds, identical stimulation parameters to the active TEAS group are delivered using a sparse-dense waveform with instantaneous stimulation (5-10 mA) to produce a mild tingling sensation matched to the active arm. After 30 seconds, the device stops delivering effective electrical current while maintaining normal indicator lights and th...더 보기
주요결과변수
결과변수측정값 설명시간 범위
Incidence of Ipsilateral Shoulder Pain (ISP) with Shoulder Movement at 24 Hours Postoperatively
Pain intensity will be assessed using the Verbal Rating Scale (VRS, 0-10, with 10 indicating worst pain). Participants will perform maximal shoulder circumduction (anterior, superior, posterior, inferior) in sitting/standing position with elbow extended, and the maximum VRS score will be recorded. ISP is defined as a VRS score ≥1.
24 Hours Postoperatively
이차결과변수
결과변수측정값 설명시간 범위
Cumulative Opioid Consumption at 24 Hours Postoperatively
Total opioid use within 24 hours postoperatively will be recorded and converted to intravenous morphine equivalents.
24 Hours Postoperatively
Incidence of Postoperative Nausea and Vomiting (PONV) at 24 Hours Postoperatively
The number of participants experiencing nausea or vomiting within 24 hours postoperatively will be recorded.
24 Hours Postoperatively
참여 도우미
적격성 기준

연령대
성인, 노인
최소 연령
18 Years
참여 가능한 성별
전체
  • Patients scheduled for unilateral thoracic surgery
  • Age ≥ 18 years, regardless of gender
  • ASA physical status classification I-III
  • No severe cardiopulmonary insufficiency or other major comorbidities

  • Pre-existing shoulder pain or functional impairment
  • Severe mental illness or cognitive impairment
  • Bilateral thoracic surgery
  • Any other conditions deemed inappropriate by the investigators (with reasons to be documented)
Shanghai Pulmonary Hospital, Shanghai, China logoShanghai Pulmonary Hospital, Shanghai, China
연구 책임자
Shiyou Wei, 책임연구자, Attending Physician, Shanghai Pulmonary Hospital, Shanghai, China
연구 대표 연락처
연락처: Shiyou Wei, 15601680099, [email protected]
연락처: Xin Lv, 13661869919, [email protected]
3 1개국에 임상시험 장소

Shanghai Municipality

Shanghai Pulmonary Hospital, Shanghai, Shanghai Municipality, 200082, China
Shanghai East Hospital,Affiliated to Tongji University, Shanghai, Shanghai Municipality, 200120, China
Fudan university Shanghai cancer center, Shanghai, Shanghai Municipality, China